期刊文献+

血管内皮生长因子与胎盘生长因子在妊娠期高血压患者血清中的表达 被引量:7

Study on the role of vascular endothelial growth factor and placenta growth factor in the pathogenesis of pregnant induced hypertension syndrome
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)与胎盘生长因子(PLGF)在妊娠期高血压(HDCP)发病中的作用。方法采用酶联免疫吸附法检测38例正常妊娠及41例HDCP患者血清VEGF与PLGF水平。结果与正常妊娠比较,HDCP患者分娩前血清VEGF与PLGF水平明显减少,差异有统计学意义(P<0.05);分娩后血清VEGF与PLGF水平无显著性差异(P>0.05)。结论 HDCP患者血清VEGF与PLGF水平减少,患者血清VEGF与PLGF水平与发病存在一定的相关性。 Objective To investigate the role of vascular endothelial growth factor (VEGF)and placenta growth tactor (PLGF)in the pathogenesis of hypertensive disorder complicating pregnancy (HDCP). Methods forty-one patients with HDCP and thirty-eight noruml late pregnant women were observed in this study. For the assay of sermn concentrations of VEGF and PIGF, enzyme-linked imnmnosorbent assay was performed. Results The serum levels of VEGF and PIGF were significantly lower in HDCP group compared with the normal control group prior to birth (P〉0.05);and were no different between HDCP group and the normal control group after parturition (/9〉0.05). Conehlsions The serum levels of VEGF and P1GF were significantly lower in HDCP, which may be one of the major causes of the etiologies of HDCP.
出处 《中华保健医学杂志》 2012年第4期292-293,共2页 Chinese Journal of Health Care and Medicine
关键词 妊娠期高血压 血管内皮生长因子 胎盘生长因子 胚胎发育 hypertensive disorder complicating pregnancy vascular endothelial growth factor placenta growth factor embryonic development
  • 相关文献

参考文献5

  • 1Shah DM. Preeclampsia :new insights [J 1. Curr Opin Nephrol Hy- pertens, 2007,16 : 213-220.
  • 2Smith GC ,Wear H. The perinat implication of angiogenic fac- tors[J]. CmT Opin Obstet Gynecol, 2009,21 : l 11-116.
  • 3Smith GC,Crossley JA,Aitken DA,et ah Circulating angiogenic factors in early pregnancy and the risk of preeclampsia,in- trauterine growth restriction,spontaneous preterm birth,and still- birth[J]. Obstet Gynecol,2007,109 : 1316-1324.
  • 4Levine RJ,Maynard SE,Qian C,et al. Circulating angiogenic factors and the risk of preeclampsia [J]. N Engl J Med, 2004,12:672-683.
  • 5Sheppard SJ, Khil RA. Risk factors and mediators of the vascu- lar dysfunction associated with hypertension in pregnancy [J]. Cardiovasc llematol Disord Drug Targets,2010,10:33-52.

同被引文献55

  • 1江苏省计划生育委员会出生缺陷干预项目组.中位倍数法及其在产前筛查中的应用[J].中华妇产科杂志,2004,39(6):428-429. 被引量:18
  • 2胡序怀,彭左旗,罗军,唐振华,李哮天,朱明伟,刘兰女,杨素霞,马旭.uE_3在唐氏综合征孕中期多指标联合筛查风险预测中的效果评估[J].中国计划生育学杂志,2006,14(6):349-352. 被引量:5
  • 3聂良华,沈其君.产前筛查试验中MOM方法的原理及其应用[J].中国医院统计,2006,13(4):302-304. 被引量:14
  • 4George EM, Granger JP. Recent insights into the pathophysiol- ogy of preeclampsia [J]. Expert Rev Obstet Gynecol, 2010, 5 (5) : 557 - 566.
  • 5Lanoix D, Gu6rin P, Vaillancourt C. Placental melatonin pro- duction and melatonin receptor expression are altered in pre- eclampsia., new insights into the role of this hormone in preg- nancy [J]. J Pineal Res, 2012, 53 (4): 417-425.
  • 6Saad AF, Kechichian T, Yin H, et al. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia [J]. Reprod Sci, 2014, 21 (1) : 138 - 145.
  • 7Genest DS, Falcao S, Gutkowska J, et al. Impact of exer- cise training on preeclampsia:potential preventive mech- anisms [ J ]. Hypertension, 2012,60 (5) : 725-728.
  • 8Bahajian K, Bajracharya S, Salahuddin S, et al. Sequential plasma angiogenic factors levels in women with suspected preeclampsia [J]. Am J Obstet Gynecol,2016,215 (1) : 89.e1-89.e10.
  • 9Lapaire O,Shennan A,Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placen- tal growth factor: current knowledge, clinical implications and future application [J]. Eur J Obstet Gynecol Reprod Biol, 2010, 151 (2) : 122-129.
  • 10Verlohren S,Galindo A,Schlembach D,et al. An auto- mated method for the determination of the sFh-1/PIGF ratio in the assessment of preeclampsia [J]. Am J Obstet Gynecol,2010,202(2) : 161.e1-161.e11.

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部